Immatics (IMTX) Divestments (2019 - 2024)
Immatics (IMTX) posted Divestments of $73.6 million for Q3 2024, up 195.8% sequentially from -$76.8 million in Q3 2023, and up 195.8% YoY from $24.9 million in Q4 2023.
Powered by 
Analysis
Immatics (IMTX) Divestments (2019 - 2024) Analysis & Trends
Immatics has reported Divestments for 5 years, with the latest figure at $73.6 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 73.59 Mn |
| Sep 30, 2023 | -76.82 Mn |
| Mar 31, 2021 | 3.09 Mn |
| Sep 30, 2020 | -12.85 Mn |
| Jun 30, 2020 | 16.16 Mn |
| Mar 31, 2020 | -21.22 Mn |
| Sep 30, 2019 | 14.30 Mn |